In The Spotlight
DDNews Cancer Research Exclusive
 
 
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
 
(Photo credit: University of Toronto)
 
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
 
 
NEWS
Study finds melanoma biomarkers that could help in tailoring immunotherapy
 
New antigen target shows promise against ovarian cancer
 
A collection of news of recently published papers
 
Researchers identify a histone that could have significance in treating aggressive breast cancer
 
Two research organizations submit recommendations to FDA aimed at greater patient participation in trials
 
Companies combine proprietary tech to create bispecific therapies against novel tumor targets
 
The U.S. Food and Drug Administration has given the green light to Bayer AG’s IND application for BAY 1905254
 
AbbVie and Calibr are collaborating on the development of T cell therapies against cancer
 
 
FEATURES
 

Columbia Business School report examines how cancer drugs have impacted mortality for patients
 
OPINION
by Dr. Eyal Talor, CEL-SCI
A look at what to expect from the second generation of cancer immunotherapies, after the progress--and pitfalls--of CAR-T cell therapies

by JK Bryan & A Zupnick, Novella
When it comes to oncology clinical trials, drug developers need to stay abreast of the rapidly evolving and competitive landscape while also remaining flexible and innovative in responding to these changes

by Dr. Alexey Eliseev, RXi
The “War on Cancer” declared by the National Cancer Act of 1971 proceeded through a series of evolutionary developments in chemotherapy, radiation treatments and targeted therapies, but until recently was only marginally successful in extending the lives of late-stage cancer patients. A major breakthrough has been achieved over the last decade with the development of immunotherapeutic treatments that empower a patient’s own immune cells to destroy tumors


 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.